Upgrade to SI Premium - Free Trial

TRAX (TRAX)

16.13 +0.16 (1.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/2/26)

Latest Headlines

Wells Fargo Starts First Tracks Biotherapeutics (TRAX) at Overweight June 8, 2026 5:00 AM - StreetInsider First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences May 21, 2026 4:15 PM - StreetInsider Form 424B3 First Tracks Biotherapeu May 15, 2026 4:12 PM - SEC Filing Form 424B3 First Tracks Biotherapeu May 14, 2026 5:13 PM - SEC Filing Form 10-Q First Tracks Biotherapeu For: Mar 31 May 14, 2026 4:33 PM - SEC Filing Form 8-K First Tracks Biotherapeu For: May 14 May 14, 2026 4:25 PM - SEC Filing First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update May 14, 2026 4:15 PM - StreetInsider Form 4 First Tracks Biotherapeu For: May 12 Filed by: Ware J. Anthony May 14, 2026 4:06 PM - SEC Filing Form 4 First Tracks Biotherapeu For: May 12 Filed by: Schmid John P. May 14, 2026 4:06 PM - SEC Filing Form 4 First Tracks Biotherapeu For: May 12 Filed by: Jain Rita May 14, 2026 4:06 PM - SEC Filing Form 4 First Tracks Biotherapeu For: May 12 Filed by: Marquet Magda May 14, 2026 4:06 PM - SEC Filing Form 4 First Tracks Biotherapeu For: May 12 Filed by: FENTON DENNIS M May 14, 2026 4:06 PM - SEC Filing Form 4 First Tracks Biotherapeu For: May 12 Filed by: Orwin John A May 14, 2026 4:06 PM - SEC Filing Form 4 First Tracks Biotherapeu For: May 12 Filed by: STONE BENJAMIN May 14, 2026 4:06 PM - SEC Filing Form 4 First Tracks Biotherapeu For: May 12 Filed by: Faga Daniel May 14, 2026 4:06 PM - SEC Filing Form 4 First Tracks Biotherapeu For: May 12 Filed by: Lizzul Paul F. May 14, 2026 4:06 PM - SEC Filing Form 4 First Tracks Biotherapeu For: May 12 Filed by: Tamboli Ajim May 14, 2026 4:06 PM - SEC Filing Form EFFECT First Tracks Biotherapeu May 13, 2026 6:07 AM - SEC Filing Form S-1 First Tracks Biotherapeu May 8, 2026 4:37 PM - SEC Filing Piper Sandler Starts First Tracks Biotherapeutics (TRAX) at Overweight May 4, 2026 2:16 AM - StreetInsider H.C. Wainwright Starts First Tracks Biotherapeutics (TRAX) at Buy April 28, 2026 6:04 AM - StreetInsider Wedbush Starts First Tracks Biotherapeutics (TRAX) at Outperform April 24, 2026 7:08 AM - StreetInsider Leerink Partners Starts First Tracks Biotherapeutics (TRAX) at Outperform April 24, 2026 6:07 AM - StreetInsider JPMorgan Starts First Tracks Biotherapeutics (TRAX) at Overweight April 23, 2026 12:58 AM - StreetInsider Barclays Starts First Tracks Biotherapeutics (TRAX) at Overweight April 22, 2026 2:47 AM - StreetInsider UBS Starts First Tracks Biotherapeutics (TRAX) at Buy April 21, 2026 3:18 AM - StreetInsider First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases April 20, 2026 9:15 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on AnaptysBio (ANAB) March 31, 2026 6:42 AM - StreetInsider AnaptysBio authorizes $100 million stock buyback plan March 27, 2026 9:00 AM - StreetInsider Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update March 27, 2026 9:00 AM - StreetInsider Full Article List